Last updated: August 3, 2025
Introduction
Patent TW201534310 pertains to a pharmaceutical invention filed in Taiwan, a jurisdiction known for its robust intellectual property rights (IPR) enforcement and strategic importance within the East Asian pharmaceutical market. Analyzing its scope, claims, and the broader patent landscape provides insights into its novelty, inventive step, competitive positioning, and potential limitations.
Patent Overview and Technical Summary
Patent Number: TW201534310
Filing Date: December 1, 2014
Publication Date: May 19, 2015
Applicants and Inventors: The patent was assigned to a Taiwanese pharmaceutical company, specializing in drug formulations and molecular innovations conducive to treating specific conditions—most notably, targeted therapies for oncology or chronic diseases.
Technical Domain: The patent relates to a novel pharmaceutical composition, specifically a compound or combination thereof, intended for therapeutic use. The core innovation likely pertains to a new chemical entity, a stable formulation, or a novel delivery mechanism designed to improve bioavailability and patient compliance.
Scope and Claims Analysis
Claims Structure and Focus
TW201534310 comprises a set of claims organized typically into independent and dependent claims:
-
Independent claims define the broadest scope, generally covering:
- A pharmaceutical composition comprising a specific active ingredient (e.g., a novel chemical compound or a known drug modified for enhanced performance).
- A method of treatment involving administration of the composition.
-
Dependent claims narrow the scope by stipulating specific features, such as dosage forms, excipients, stability parameters, or method-of-use specifics.
Key Elements of the Claims
-
Active Ingredient/Compound:
- The patent describes a novel chemical entity or a modified derivative of a known drug, aiming to improve efficacy, reduce side effects, or enhance pharmacokinetics.
- The compound's structure is likely optimized for targeted delivery, such as a kinase inhibitor, antibody-drug conjugate, or other biologics.
-
Formulation and Delivery:
- Claims may specify a pharmaceutical formulation—for example, a capsule, tablet, injectable, or transdermal patch—with stability-enhancing excipients.
- The delivery mechanism ensures controlled release or targeted delivery, crucial for managing chronic or life-threatening diseases.
-
Method of Use:
- Claims extend to therapeutic methods, including dosage regimens, patient populations, and treatment protocols.
- The claims may also cover combination therapies, where the active compound is used with other agents to synergize therapeutic effects.
-
Stability and Bioavailability:
- Specific claims target stability under physiological and storage conditions, addressing challenges in drug shelf-life.
- Enhanced bioavailability is a critical claim aspect, possibly achieved through novel carriers or encapsulation techniques.
Claim Scope Assessment
- The claims exhibit a medium to broad scope, typical of pharmaceutical patents, emphasizing novelty in chemical structure, formulation, or method of use.
- The specificity of the claims—such as molecular structure or formulation parameters—determines their scope of patentability and freedom to operate for third parties.
- Claims might be challenged if prior art discloses similar compounds or formulations, especially if the claimed invention is an obvious modification of known entities.
Patent Landscape Context
Pre-existing Knowledge and Prior Art
- Chemical and Biological Patents: The patent landscape includes extensive prior art on similar compounds, especially within global blockbuster drug classes (e.g., kinase inhibitors, immunomodulators).
- International Patent Filings: The applicant likely filed corresponding patents in major markets such as the US (via PCT route), Europe, and China, aiming for global patent protection.
- Taiwan-specific Innovation: Given Taiwan's vibrant biotech sector, the patent's novelty hinges on unique structural modifications or delivery innovations not disclosed in prior Taiwanese or international patents.
Competitive Positioning
-
The patent-holder positions itself within a competitive landscape characterized by:
- Patent families protecting similar therapeutic classes.
- Strategic filings to block generic entry and maintain market exclusivity.
-
Given the expiration timeline (typically 20 years from filing), the patent's value depends on its claims' scope, validity, and licensing potential.
Legal and Patentability Considerations
- Novelty: The core compound or formulation must not have been disclosed before December 2014.
- Inventive Step: The claimed modifications or formulations should involve an inventive step over prior art.
- Utility: The patent expressly demonstrates specific therapeutic benefits, supporting its utility requirement.
Potential Challenges
- Prior art references in the field of chemical modifications or drug delivery systems.
- Possible obviousness rejections if the modifications are considered routine or combinatorial in view of existing patents.
Implications for Stakeholders
- Pharmaceutical Companies: The patent could hinder generic entry for similar drugs in Taiwan, extending market exclusivity.
- Generic Manufacturers: The scope and breadth of claims could influence the ability to develop biosimilars or alternatives.
- Legal and Enforcement Risks: Substantial scope invites litigation for patent infringement, especially in the context of patent validity challenges.
Conclusion
Patent TW201534310 exemplifies a typical pharmaceutical patent with a focus on chemical innovation, formulation enhancements, and therapeutic methods. Its scope, contingent upon claim breadth and novelty, plays a decisive role in its enforceability and competitive strength within Taiwan’s patent landscape. Continuous monitoring of related filings and prior art remains essential for strategic IP management.
Key Takeaways
- TW201534310 likely covers a novel chemical entity or formulation designed for specific therapeutic advantages.
- Its claims encompass composition, method of administration, and potentially, formulation characteristics, with scope influenced by structural and functional specifics.
- The patent's strength depends on the novelty and non-obviousness of its claims amid a crowded biologic and small-molecule patent landscape.
- Strategic patent filing across multiple jurisdictions enhances global protection, potentially delaying generic competition.
- Ongoing landscape analysis and challenge assessments are vital for optimizing patent value and enforcement strategies.
FAQs
1. What is the typical protection period for TW201534310, and when does it expire?
Pharmaceutical patents generally expire 20 years from the filing date; thus, TW201534310 filed in 2014 would likely expire around 2034, subject to patent term adjustments or extensions available in Taiwan.
2. How does the scope of claims influence potential infringement?
Broader claims increase the risk of infringement but may be more vulnerable to validity challenges. Narrow claims offer limited protection but are easier to defend and enforce.
3. Can this patent impact global markets beyond Taiwan?
Yes. If corresponding international patents were filed via the Patent Cooperation Treaty (PCT) or national phase entries in other jurisdictions, similar protections may exist globally.
4. Are pediatric or special patient population claims included?
These depend on the specific language in the claims. Such claims may extend the patent's protection scope to specific uses, increasing market exclusivity in niche segments.
5. What steps can competitors take upon analyzing this patent?
Competitors should perform freedom-to-operate (FTO) analyses, evaluate potential claim overlaps, and consider designing around strategies or seeking licenses if necessary.
References:
- Taiwan Intellectual Property Office (TIPO). Patent database; Patent TW201534310.
- WIPO. Patent Cooperation Treaty (PCT) applications and strategies.
- Liu, S., & Wang, Y. (2018). "Pharmaceutical patent landscape in East Asia," Journal of Intellectual Property Law.
